Accession Number:

ADA636997

Title:

Targeting Sphingosine-1-Phosphate Axis in Obesity-Promoted Breast Cancer

Descriptive Note:

Annual rept. 1 may 2015-30 Apr 2016

Corporate Author:

VIRGINIA COMMONWEALTH UNIV RICHMOND

Personal Author(s):

Report Date:

2016-05-01

Pagination or Media Count:

14.0

Abstract:

Obesity, which induces low-grade inflammation, is a known risk factor for worse prognosis in many cancers including breast. We found that sphingosine-1-phosphate S1P produced by sphingosine kinases SphKs plays a critical role in obesity-related inflammation and breast cancer. Obesity increased S1P in the tumor microenvironment, as well as in the primary tumors. FTY720, a functional antagonist of S1PR1, dramatically decreased cancer progression by reducing expressions of SphK1 and S1PR1, and inflammatory cytokines including IL-6. Our results suggest a critical role for S1P in obesity-related inflammation and FTY720, an S1P axis inhibitor, appears to be a promising treatment for breast cancer in the obese condition, could be due to its effect on reactivate ERa expression and sensitize breast cancer cells to tamoxifen therapy.

Subject Categories:

  • Medicine and Medical Research

Distribution Statement:

APPROVED FOR PUBLIC RELEASE